700 patients110,866 observations180 daysLIVE

Patient P-02087

Synthetic patientMETA-24 · Day 146 · 55–64 · F · baseline S01Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
25%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S01
  2. Day 108 BR-03 recommendedBehavioural Recommendation BR-03
  3. Day 109 Patient acceptedStarted BR-03 in the companion
  4. Day 116 No meaningful changeBehavioural Recommendation BR-03
  5. Day 123 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 123.

Primary contributors, last 14 days
  • Nutritional resilience-5
  • GI instability+4
  • Toxicity+3
  • Treatment adherence+2

What helped?

  • Behavioural Recommendation BR-03Day 108
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
77 min
worsening · -5.0 vs previous 14 d
Sleep duration
Wearable
5.7 h
stable · +0.0 vs previous 14 d
Energy level
Daily log
4.9/10
worsening · -0.4 vs previous 14 d
Steps
Wearable
9,268
worsening · -606 vs previous 14 d
GI burden
Companion
25.5/100
worsening · +6.4 vs previous 14 d
Adherence
Companion
86 %
stable · +2.4 vs previous 14 d
Sleep quality
Wearable
36/100
worsening · -1.7 vs previous 14 d
Glucose, CGM daily mean
CGM
136 mg/dL
stable · +2.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 63 from the failing basin, 39 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -2.7 next day on high-intake days · n 22
Would not help
  • BR-03 Behavioural Recommendation
    already tried, no meaningful change
  • Keep caffeine low
    GI +2.7 next day on high-intake days · n 15
  • Keep alcohol low
    GI +2.3 next day on high-intake days · n 23
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Caffeine
    +2.7detractor · 95%
  • Protein
    -2.7supporter · 95%
  • Alcohol
    +2.3detractor · 95%
  • Insoluble fibre
    -1no signal · 32%
  • Simple carbohydrates
    -0.8no signal · 29%
  • Dietary fat load
    +0.6no signal · 17%
  • Histamine load
    +0.3no signal · 15%
  • Ultra-processed food
    0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 45
    • WearableResting HR 75 bpm
    • WearableShort sleep window
  • Mucosal barrier integrity 40
    • MicrobiomeAkkermansia low → thinner mucus layer
    • WearableSleep 5.7 h, below personal baseline
  • Drug metabolism and exposure 40
    • DNACYP2D6 poor metabolizer → higher exposure
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 4.2 · butyrate capacity 45/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
58 ms
Sleep
5.9 h
Steps
9,148
Resting HR
77 bpm
Daily log: GI score 26, nutritional resilience 61, adherence 86.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0209349%S05AD-05no change40
P-0228549%S14AD-05no change39
P-0203142%S12AD-05improved47
P-0252247%S01BR-03no change40
P-0263845%S01BR-03improved41
P-0230844%S13BR-03no change27
P-0226743%S09BR-03no change45
P-0243940%S08BR-03no change40
P-0228036%S07BR-03no change50
P-0232535%S19BR-03no change33
P-0256433%S15BR-03improved32
P-0248332%S06BR-03no change64